XML 90 R28.htm IDEA: XBRL DOCUMENT

Balance Sheet Accounts (Tables)

12 Months Ended

Dec. 31, 2019

Prepaid and other current assets consist of the following:



	December 31,
	2019		2018
Advances to commercial manufacturers	$	2,462	$	2,700
Prepaid FDA user fee	6,345		1,540
Prepaid insurance	191		150
Prepaid income taxes	4,661		5,739
All other	1,445		134
Total Prepaid expenses and other current assets	$	15,104	$	10,263

Accrued expenses and other liabilities consist of the following:



	December 31,
	2019		2018
Accrued expenses
Royalties payable to commercial partners	$	6,004	$	7,139
Accrued research & development	1,686		1,245
Accrued professional fees	1,926		2,408
Accrued salary and other compensation	8,083		5,049
Accrued product costs	8,364		5,869
All other	2,298		1,809
Total Accrued expenses and other liabilities	$	28,361	$	23,519

Lease related disclosures consist of the following:



	December 31,
	2019
Right of use (ROU) asset, net included in Other assets	$	3,716
Lease liability included with Other long-term liabilities	$	3,000
Lease liability included with Accrued expenses and other liabilities	$	1,101
YTD 2019 depreciation of ROU asset	$	1,159
YTD 2019 related rent expense	$	1,146
YTD operating cash flows from operating leases	$	952
YTD operating lease costs	$	1,146
Weighted-average remaining lease term - operating leases	5.0 years
Weighted-average discount rate - operating leases	6		%

As of December 31, 2019, the future minimum lease commitments for the Company's two leases were as follows:

As of December 31, 2018, the future minimum lease commitments for the Company's two leases were as follows: